| 000 | 01371 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511201035.0 | ||
| 264 | 0 | _c19900816 | |
| 008 | 199008s 0 0 eng d | ||
| 022 | _a0160-2446 | ||
| 024 | 7 |
_a10.1097/00005344-199006000-00003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrouwer, R M | |
| 245 | 0 | 0 |
_aAcute effects and mechanism of action of ketanserin in patients with primary Raynaud's phenomenon. _h[electronic resource] |
| 260 |
_bJournal of cardiovascular pharmacology _cJun 1990 |
||
| 300 |
_a868-76 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBlood Gas Monitoring, Transcutaneous |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFingers _xblood supply |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKetanserin _xtherapeutic use |
| 650 | 0 | 4 | _aLasers |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOxygen _xblood |
| 650 | 0 | 4 |
_aPhentolamine _xpharmacology |
| 650 | 0 | 4 | _aPlethysmography |
| 650 | 0 | 4 |
_aPrazosin _xpharmacology |
| 650 | 0 | 4 |
_aRaynaud Disease _xdrug therapy |
| 650 | 0 | 4 |
_aRegional Blood Flow _xdrug effects |
| 650 | 0 | 4 |
_aSkin Temperature _xdrug effects |
| 700 | 1 | _aWenting, G J | |
| 700 | 1 | _aSchalekamp, M A | |
| 773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 15 _gno. 6 _gp. 868-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00005344-199006000-00003 _zAvailable from publisher's website |
| 999 |
_c1701310 _d1701310 |
||